CS 060304
Alternative Names: CS-060304Latest Information Update: 30 Jul 2024
At a glance
- Originator Cascade Pharmaceuticals
- Class Hepatoprotectants; Small molecules
- Mechanism of Action Thyroid hormone receptor beta agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Non-alcoholic steatohepatitis
Most Recent Events
- 16 Jul 2024 Preclinical trials in Non-alcoholic steatohepatitis in China (PO)
- 14 Jul 2024 Cascade pharmaceuticals plans a phase I trial for non-alcoholic steatohepatitis (In Volunteers) in China (PO, Tablet) (NCT06485245)
- 18 Jun 2024 NMPA approves IND application for CS 06030 in non-alcoholic steatohepatitis